SSG
MDCO

Summit Securities Group’s Medicines Co MDCO Stock Holding History

Summit Securities Group’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-250
Closed -$2.12M – 541
2019
Q4 		$2.12M Sell
250
-250
-50% -$16.7K 0.16% 132
2019
Q3 		$2.5M Buy
+500
New +$19.9K 0.22% 72

Other funds holding MDCO

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Summit Securities Group's MDCO Position: Q4 2019 in Review

Summit Securities Group sold out of Medicines Co (MDCO) in Q4 2019, closing a stake of 7,000 shares — an estimated $467K sold.

Summit Securities Group first reported a position in MDCO in Q1 2014 and held it in 2 quarters. The position peaked at $350K in Q3 2019. 284 funds tracked by Wall St. Rank hold MDCO as of Q4 2019.

  • Summit Securities Group reported no remaining Medicines Co position as of Q4 2019 after selling out during the quarter.
  • Summit Securities Group sold 7,000 Medicines Co shares in Q4 2019, an estimated $467K.
  • Summit Securities Group first reported a position in Medicines Co in Q1 2014 and held it in 2 quarters.
  • Summit Securities Group's Medicines Co position peaked at $350K in Q3 2019.
  • 284 funds tracked by Wall St. Rank held Medicines Co as of Q4 2019.

Based on Summit Securities Group's 13F filing for Q4 2019, filed 13 Jan 2020.